The role of LKB1 in lung cancer

High Cancer Risk in Peutz–Jeghers Syndrome: A Systematic Review and Surveillance Recommendations

(2010) M G F van Lier et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

LKB1/KRAS mutant lung cancers constitute a genetic subset of NSCLC with increased sensitivity to MAPK and mTOR signalling inhibition

(2009) C L Mahoney et al.   BRITISH JOURNAL OF CANCER

Sunitinib Prolongs Survival in Genetically Engineered Mouse Models of Multistep Lung Carcinogenesis

(2009) L. Gandhi et al.   Cancer Prevention Research

BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer

(2009) S. Rodriguez-Nieto et al.   CARCINOGENESIS

A gene-alteration profile of human lung cancer cell lines

(2009) Raquel Blanco et al.   HUMAN MUTATION

Enhanced activity of the CREB co-activator Crtc1 in LKB1 null lung cancer

(2009) T Komiya et al.   ONCOGENE

Phosphatidylinositol Ether Lipid Analogues Induce AMP-Activated Protein Kinase Dependent Death in LKB1-Mutant Non Small Cell Lung Cancer Cells

(2008) R. M. Memmott et al.   CANCER RESEARCH

The Tumor Suppressor LKB1 Regulates Lung Cancer Cell Polarity by Mediating cdc42 Recruitment and Activity

(2008) S. Zhang et al.   CANCER RESEARCH

Frequent BRG1/SMARCA4-inactivating mutations in human lung cancer cell lines

(2008) Pedro P. Medina et al.   HUMAN MUTATION

Somatic mutations affect key pathways in lung adenocarcinoma

(2008) Li Ding et al.   NATURE